Feasibility & acceptability study of Rewind therapy for PTSD

  • Research type

    Research Study

  • Full title

    A pilot feasibility and acceptability study of Rewind therapy for PTSD as a low intensity psychological intervention following single incident trauma

  • IRAS ID

    323733

  • Contact name

    Rachel Belin

  • Contact email

    rbelin1@sheffield.ac.uk

  • Sponsor organisation

    University of Sheffield

  • Duration of Study in the UK

    1 years, 2 months, 31 days

  • Research summary

    Post-traumatic stress disorder (PTSD) is a disabling and distressing mental health condition. Current recommendations for psychological therapies to treat PTSD specify that these should be trauma-focused. These therapies are considered 'high-intensity' within Improving Access to Psychological Therapies (IAPT) services, and are provided by highly qualified therapists across many sessions. This results in long waiting times for therapies which can have poor acceptability.

    This mixed methods case series aims to examine the feasibility and acceptability of delivering a low-intensity therapy for PTSD (Rewind) within an IAPT service. Rewind is a brief therapy requiring 4 to 6 sessions of treatment. Psychological wellbeing practitioners (PWPs) will receive training to deliver this therapy, which will be offered as a waitlist intervention. IAPT patients screened for PTSD and placed on a waiting list for high-intensity therapy will be invited to participate, and will have the option of returning to the waiting list and further therapy if required.

    Feasibility will be assessed using rates of treatment fidelity and rates of reliable and clinically significant change on a PTSD measure (Impact of Event Scale) and IAPT minimum dataset. This will include examining rates of clinical deterioration. These outcomes may give some initial indication of Rewind's effectiveness in this context. Qualitative feedback will also be gathered from psychological wellbeing practitioners about their experience of delivering the intervention.

    Rewind's acceptability will be assessed using rates of patient uptake and dropout, which will be compared with rates for existing high-intensity therapies for PTSD. Patient need for further high-intensity therapy will also be examined, and qualitative interviews will be completed to capture patient experience of Rewind therapy.

  • REC name

    Yorkshire & The Humber - Leeds West Research Ethics Committee

  • REC reference

    23/YH/0081

  • Date of REC Opinion

    20 Apr 2023

  • REC opinion

    Favourable Opinion